{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:51:59Z","timestamp":1648871519786},"reference-count":24,"publisher":"Georg Thieme Verlag KG","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pneumologie"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>\n          Einleitung\u2002Die Implantation eines pleuralen getunnelten Dauerkatheters (indwelling pleural catheter\u200a=\u200aIPC) stellt bei symptomatischen rezidivierenden benignen und malignen Pleuraerg\u00fcssen (BPE und MPE) neben einer Pleurodese eine weitere etablierte Therapiemethode dar.<\/jats:p><jats:p>Zur Sicherheit des IPC, insbesondere zu Pneumothorax und Katheterinfektionen, existierten wenige Studien.<\/jats:p><jats:p>Ziel unserer Untersuchung war, die Komplikationsh\u00e4ufigkeit nach IPC-Anlage und deren pr\u00e4diktive Faktoren bei Patienten mit BPE vs. MPE zu ermitteln.<\/jats:p><jats:p>\n          Methoden\u2002Retrospektive Analyse aller IPC-Implantationen im Bereich Pneumologie am Universit\u00e4tsklinikum Dresden im Zeitraum von 2015\u200a\u2013\u200a2018.<\/jats:p><jats:p>\n          Ergebnisse\u2002Bei 86 Patienten (je 43\u200am\/f; Alter 66,9\u200a\u00b1\u200a13,3 Jahre) wurde bei symptomatischem BPE und MPE ein IPC implantiert. Ein BPE bzw. MPE bestand bei 12,8\u200a% (11\/86) bzw. 87,2\u200a% (75\/86) der Erkrankten.<\/jats:p><jats:p>Als Sofortkomplikation nach IPC-Anlage war bei 43\/86 (50\u200a%) Patienten ein meist kleiner, asymptomatischer Pneumothorax nachweisbar. 34\/43 (79\u200a%) Patienten bedurften diesbez\u00fcglich keiner spezifischen Therapie. Bei 9\/43 war ein IPC-Sog im Median \u00fcber 3 Tage erforderlich. 8\/43 Patienten wiesen einen gro\u00dfen Pneumothorax mit partieller\/kompletter Regredienz im Median nach 2 Tagen auf.<\/jats:p><jats:p>Bei 15,1\u200a% (13\/86) der Gesamtgruppe und 36,4\u200a% (4\/11) der BPE vs. 12\u200a% (9\/75) der MPE kam es im Median nach 87 (BPE\/MPE 116\/87) Tagen zu einer Katheterinfektion. Diese war bei BPE (p\u200a=\u200a0,035), gro\u00dfem Pneumothorax (4\/8 Patienten; p\u200a=\u200a0,015) und l\u00e4ngerer Katheterverweildauer (124\u200a\u00b1\u200a112 vs. 71\u200a\u00b1\u200a112 Tage; p\u200a=\u200a0,07) h\u00e4ufiger.<\/jats:p><jats:p>\n          Schlussfolgerung\u2002Kleine Pneumothoraces sind h\u00e4ufig nach IPC-Implantation, bed\u00fcrfen aber meist keiner spezifischen Therapie. Bei 15,1\u200a% aller Patienten war im Median nach 87 Tagen eine Katheterinfektion nachweisbar. Diese trat h\u00e4ufiger bei BPE, l\u00e4ngerer Katheterverweildauer und gro\u00dfen Pneumothoraces auf.<\/jats:p>","DOI":"10.1055\/a-1201-3682","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T22:49:54Z","timestamp":1594766994000},"page":"864-870","source":"Crossref","is-referenced-by-count":0,"title":["Komplikationen nach pleuralem getunnelten Dauerkatheter bei symptomatischen rezidivierenden benignen und malignen Pleuraerg\u00fcssen"],"prefix":"10.1055","volume":"74","author":[{"given":"S.","family":"Langner","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Koschel","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"},{"name":"Fachkrankenhaus Coswig, Abteilung Innere Medizin und Pneumologie, Lungenzentrum, Coswig"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kleymann","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tausche","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Karl","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Frenzen","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Heberling","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schulte-Hubbert","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Halank","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kolditz","sequence":"additional","affiliation":[{"name":"Bereich Pneumologie, Medizinische Klinik I, Universit\u00e4tsklinikum Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","author":"A C Bibby","year":"2018","journal-title":"Eur Respir J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1676648","article-title":"Indwelling Pleural Catheter Placement for Nonmalignant Pleural Effusions","author":"K Bramley","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.chest.2016.10.052","article-title":"Management of Benign Pleural Effusions Using Indwelling Pleural Catheters: A Systematic Review and Meta-analysis","volume":"151","author":"M Patil","year":"2017","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MCP.0000000000000574","article-title":"Indwelling pleural catheters for benign pleural effusions: What is the evidence?","volume":"25","author":"M Aboudara","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M","article-title":"A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions","volume":"86","author":"J B Putnam","year":"1999","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2214\/ajr.165.5.7572489","article-title":"Quantification of pneumothorax size on chest radiographs using interpleural distances: Regression analysis based on volume measurements from helical CT","volume":"165","author":"C D Collins","year":"1995","journal-title":"Am J Roentgenol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2019.pa3836","article-title":"IPC-related pleural infection vs. colonisation \u2013 to treat or not to treat?","author":"K Ferguson","year":"2019"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"N M Rahman","year":"2011","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/s1806-37562016000000021","article-title":"Use of indwelling pleural catheters for the definitive treatment of malignant pleural effusion","volume":"43","author":"F C Abr\u00e3o","year":"2017","journal-title":"J Bras Pneumol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1055\/s-0043-123656","article-title":"Effektivit\u00e4t und Sicherheit von getunnelten pleuralen Dauerkathetern","volume":"143","author":"E L\u00fccke","year":"2018","journal-title":"Zentralblatt f\u00fcr Chir \u2013 Zeitschrift f\u00fcr Allg Visz Thorax- und Gef\u00e4\u00dfchirurgie"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/1753465817721146","article-title":"A single institution experience for the management of recurrent pleural effusions with tunneled pleural catheter and its evolution","volume":"11","author":"T Raman","year":"2017","journal-title":"Ther Adv Respir Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000501","article-title":"Indwelling pleural catheters for non-malignant pleural effusions: Report on a single centre\u2019s 10 years of experience","author":"N Frost","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-1002-8","article-title":"Indwelling pleural catheters for malignancy-associated pleural effusion: Report on a single centre\u2019s ten years of experience","author":"N Frost","year":"2019","journal-title":"BMC Pulm Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.21037\/jtd.2018.04.160","article-title":"Indwelling pleural catheters: Complications and management strategies","volume":"10","author":"M Chalhoub","year":"2018","journal-title":"J Thorac Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1513\/AnnalsATS.201610-785OC","article-title":"Indwelling pleural catheters for patients with hematologic malignancies a 14-year, single-center experience","volume":"14","author":"S A Faiz","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1378\/chest.14-3119","article-title":"The use of indwelling tunneled pleural catheters for recurrent pleural effusions in patients with hematologic malignancies: A multicenter study","volume":"148","author":"C R Gilbert","year":"2015","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.chest.2018.07.001","article-title":"Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single-Center Series of Outcomes and Complications","volume":"155","author":"C Kniese","year":"2019","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.chest.2018.08.1034","article-title":"Indwelling Tunneled Pleural Catheters for Refractory Hepatic Hydrothorax in Patients With Cirrhosis: A Multicenter Study","volume":"155","author":"S Shojaee","year":"2019","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1378\/chest.12-3103","article-title":"Clinical outcomes of indwelling pleural catheter-related pleural infections: An international multicenter study","volume":"144","author":"E TH Fysh","year":"2013","journal-title":"Chest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.14-2401","article-title":"Intrapleural fibrinolysis for the treatment of indwelling pleural catheter-related symptomatic loculations: A multicenter observational study","volume":"148","author":"R Thomas","year":"2015","journal-title":"Chest"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.457","article-title":"Very low-dose intrapleural tPA for indwelling pleural catheter-associated symptomatic fluid loculation","author":"N SH Lan","year":"2019","journal-title":"Respirol Case Reports"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"PA3835","DOI":"10.1183\/13993003.congress-2019.pa3835","article-title":"Outcomes of intrapleural tissue plasminogen activator (tPA) and deoxyribnuclease (DNase) for IPC-related pleural infection","volume":"54","author":"D Fitzgerald","year":"2019","journal-title":"Eur Respir J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1055\/s-0032-1325881","article-title":"PleurX drainage catheter for palliative treatment of malignant pleural effusion","volume":"66","author":"M Dilkaute","year":"2012","journal-title":"Pneumologie"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0016-5085(93)90284-J","article-title":"Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites","volume":"104","author":"M Andreu","year":"1993","journal-title":"Gastroenterol"}],"container-title":["Pneumologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1201-3682.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T01:12:38Z","timestamp":1607476358000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1201-3682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,8]]},"published-print":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1201-3682","relation":{},"ISSN":["0934-8387","1438-8790"],"issn-type":[{"value":"0934-8387","type":"print"},{"value":"1438-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]}}}